Sensorion Provides Preliminary Documents for the Extraordinary General Meeting of April 14th, 2022
MONTPELLIER, France--(BUSINESS WIRE)--Regulatory News: Sensorion (FR0012596468 – ALSEN) (Paris:ALSEN) a pioneering clinical-stage biotechnology company which specializes in the development of...